Pernilla Meijer is a seasoned executive with extensive experience in the pharmaceutical industry. She specializes in building, scaling, and transforming organizations. She has held diverse global, regional, and local roles throughout her career, including Market Access, Business Unit Head, and General Manager. She consistently drives growth through successful product launches and strategic market positioning.
In her most recent role as VP General Manager at Novartis, Pernilla built and led an internal commercial agency comprising five specialized departments—Market Access, Insights and Analytics, Field Force Operations, Creative and Digital, and Learning—delivering high-value services across the enterprise.
As CEO of Ciencia AB, Schain Research AB, and Ciencia Technology AB, Pernilla brings deep expertise in consultancy, market access, real-world evidence (RWE), and the full lifecycle of medicines—from early development to new launches and established products. Her leadership is characterized by strategic vision, hands-on execution, and a commitment to cultivating healthy, engaged, high-performing organizations.
Pernilla holds an Executive MBA from the University of Cumbria, Switzerland, and advanced studies in AI and business strategy from MIT Sloan and MIT CSAIL, USA. She is also a certified professional board member and holds an engineering degree in Chemistry and Microbiology from Mälardalen University, Sweden.